Vilazodone (Viibryd®): An organized list of references

1. 1. Prescribing Information: Available at http://www.allergan.com/assets/pdf/viibryd_pi
      
   2. Review article: Citrome L. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant – what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Pract 2012; 66: 356–68.
   3. Review article about sexual dysfunction with vilazodone: Clayton AH, Kennedy SH, Edwards JB, Gallipoli S, Reed CR. The effect of vilazodone on sexual function during the treatment of major depressive disorder. J Sex Med. 2013;10(10):2465-2476.
   4. Randomized controlled trial: Khan A, Cutler AJ, Kajdasz DK, et al. A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder. J Clin Psychiatry. 2011;72(4):441-447.
   5. Randomized controlled trial: Rickels K, Athanasiou M, Robinson DS, et al. Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2009;70(3):326-333.
   6. One year open-label extension study: Robinson DS, Kajdasz DK, Gallipoli S, Whalen H, Wamil A, Reed CR. A 1-year, open-label study assessing the safety and tolerability of vilazodone in patients with major depressive disorder. J Clin Psychopharmacol. 2011;31(5):643-6.

---

Related Pages

Vilazodone (Viibryd): Basic Information (Free)

Vilazodone (Viibryd®): Efficacy

Vilazodone (Viibryd®): Pharmacological Effects

Vilazodone (Viibryd®): Drug Interactions

Vilazodone (Viibryd®): Adverse Effects

Podcast: 14 Key questions about vilazodone (Viibryd)

Antidepressants: Index and Links

Psychopharmacology: Index and Links